Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study

Weide, Benjamin; Martens, Alexander; Wistuba-Hamprecht, Kilian; Zelba, Henning; Maier, Ludwig; Lipp, Hans-Peter; Klumpp, Bernhard D.; Soffel, Daniel; Eigentler, Thomas K.; Garbe, Claus

dc.contributor.author	Weide, Benjamin Matthias
dc.contributor.author	Martens, Alexander
dc.contributor.author	Wistuba-Hamprecht, Kilian
dc.contributor.author	Zelba, Henning
dc.contributor.author	Lipp, Hans-Peter
dc.contributor.author	Soffel, Daniel
dc.contributor.author	Garbe, Claus
dc.contributor.author	Klumpp, Bernhard
dc.contributor.author	Eigentler, Thomas
dc.date.accessioned	2017-12-11T16:06:29Z
dc.date.available	2017-12-11T16:06:29Z
dc.date.issued	2017
dc.identifier.issn	1432-0851
dc.identifier.uri	http://hdl.handle.net/10900/79197
dc.language.iso	en	en
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00262-016-1944-0	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.subject.ddc	570	de_DE
dc.title	Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma-safety and efficacy in a phase II study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20170815222223_01258
utue.publikation.seiten	441-449	de_DE
utue.personen.roh	Weide, Benjamin
utue.personen.roh	Martens, Alexander
utue.personen.roh	Wistuba-Hamprecht, Kilian
utue.personen.roh	Zelba, Henning
utue.personen.roh	Maier, Ludwig
utue.personen.roh	Lipp, Hans-Peter
utue.personen.roh	Klumpp, Bernhard D.
utue.personen.roh	Soffel, Daniel
utue.personen.roh	Eigentler, Thomas K.
utue.personen.roh	Garbe, Claus
dcterms.isPartOf.ZSTitelID	Cancer Immunology Immunotherapy	de_DE
dcterms.isPartOf.ZS-Issue	4	de_DE
dcterms.isPartOf.ZS-Volume	66	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE